Details for New Drug Application (NDA): 050661
✉ Email this page to a colleague
NDA 050661 describes IDAMYCIN, which is a drug marketed by Pfizer and is included in two NDAs. Additional details are available on the IDAMYCIN profile page.
The generic ingredient in IDAMYCIN is idarubicin hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
The generic ingredient in IDAMYCIN is idarubicin hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Summary for 050661
| Tradename: | IDAMYCIN |
| Applicant: | Pfizer |
| Ingredient: | idarubicin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050661
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 10MG/VIAL | ||||
| Approval Date: | Sep 27, 1990 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 5MG/VIAL | ||||
| Approval Date: | Sep 27, 1990 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 20MG/VIAL | ||||
| Approval Date: | Apr 25, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
